Pimavanserin - Generic Drug Details
✉ Email this page to a colleague
Recent Clinical Trials for pimavanserin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University | Phase 2 |
State University of New York - Downstate Medical Center | Early Phase 1 |
ACADIA Pharmaceuticals Inc. | Early Phase 1 |
Generic filers with tentative approvals for PIMAVANSERIN
Applicant | Application No. | Strength | Dosage Form |
⤷ Try a Trial | ⤷ Try a Trial | EQ 34MG BASE | CAPSULE;ORAL |
⤷ Try a Trial | ⤷ Try a Trial | 34MG | CAPSULE;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.